EDIT vs. SPYI
Compare and contrast key facts about Editas Medicine, Inc. (EDIT) and NEOS S&P 500 High Income ETF (SPYI).
SPYI is an actively managed fund by Neos Investments. It was launched on Aug 29, 2022.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EDIT or SPYI.
Correlation
The correlation between EDIT and SPYI is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
EDIT vs. SPYI - Performance Comparison
Key characteristics
EDIT:
-1.16
SPYI:
2.18
EDIT:
-3.17
SPYI:
2.88
EDIT:
0.66
SPYI:
1.46
EDIT:
-0.89
SPYI:
3.17
EDIT:
-1.59
SPYI:
15.53
EDIT:
55.41%
SPYI:
1.35%
EDIT:
75.81%
SPYI:
9.63%
EDIT:
-98.62%
SPYI:
-10.19%
EDIT:
-98.62%
SPYI:
-1.23%
Returns By Period
In the year-to-date period, EDIT achieves a -87.66% return, which is significantly lower than SPYI's 20.66% return.
EDIT
-87.66%
-48.77%
-75.39%
-88.46%
-48.00%
N/A
SPYI
20.66%
0.13%
9.48%
20.96%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EDIT vs. SPYI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and NEOS S&P 500 High Income ETF (SPYI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EDIT vs. SPYI - Dividend Comparison
EDIT has not paid dividends to shareholders, while SPYI's dividend yield for the trailing twelve months is around 10.77%.
| TTM | 2023 | 2022 | |
|---|---|---|---|
EDIT Editas Medicine, Inc. | 0.00% | 0.00% | 0.00% |
SPYI NEOS S&P 500 High Income ETF | 10.77% | 12.01% | 4.10% |
Drawdowns
EDIT vs. SPYI - Drawdown Comparison
The maximum EDIT drawdown since its inception was -98.62%, which is greater than SPYI's maximum drawdown of -10.19%. Use the drawdown chart below to compare losses from any high point for EDIT and SPYI. For additional features, visit the drawdowns tool.
Volatility
EDIT vs. SPYI - Volatility Comparison
Editas Medicine, Inc. (EDIT) has a higher volatility of 35.06% compared to NEOS S&P 500 High Income ETF (SPYI) at 3.19%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than SPYI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.